Protocol Ledger

NCT05462821 · Phase III · COMPLETED

Full-Time Occlusion Therapy for Intermittent Exotropia in Children

Interventional Phase III clinical trial protocol NCT05462821 sponsored by Jaeb Center for Health Research in Rare Genetic, Women's Health, and Other, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2022-11-01 Enrollment: 73 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT05462821
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)73 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)3 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT05462821
Protocol FieldVerified Registry Value
NCT IdentifierNCT05462821
Consolidated Lead SponsorJaeb Center for Health Research
Therapeutic Condition CohortRare Genetic, Women's Health, and Other
Clinical Trial PhasePhase III
Overall Recruitment StatusCOMPLETED
Registered Enrollment73 participants (ACTUAL)
Registered Start Date2022-11-01
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Rare Genetic, Women's Health, and Other Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI